Gallina, A.; Gallina, M.; Cona, A.; Vitulo, P.; Mularoni, A.; Provenzani, A.
Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge. Pharmaceuticals 2026, 19, 162.
https://doi.org/10.3390/ph19010162
AMA Style
Gallina A, Gallina M, Cona A, Vitulo P, Mularoni A, Provenzani A.
Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge. Pharmaceuticals. 2026; 19(1):162.
https://doi.org/10.3390/ph19010162
Chicago/Turabian Style
Gallina, Anna, Matteo Gallina, Andrea Cona, Patrizio Vitulo, Alessandra Mularoni, and Alessio Provenzani.
2026. "Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge" Pharmaceuticals 19, no. 1: 162.
https://doi.org/10.3390/ph19010162
APA Style
Gallina, A., Gallina, M., Cona, A., Vitulo, P., Mularoni, A., & Provenzani, A.
(2026). Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge. Pharmaceuticals, 19(1), 162.
https://doi.org/10.3390/ph19010162